There are 14 resources available
Welcome and Introduction
Presenter: H. H. F. Loong, HK, A. Sartore-Bianchi, IT and H. Zhu, CN
Session: Welcome and Introduction
Resources:
Slides
Webcast
Advances in NTRK-fused tumours classification and diagnosis
Presenter: S. Yip, CA
Session: Session 1
Resources:
Slides
Webcast
The clinical and pathological spectrum of NTRK-rearranged mesenchymal tumours
Presenter: J. Wang, CN
Session: Session 2
Resources:
Slides
Webcast
Challenges in molecular and pathological diagnosis of NTRK fusions in big killer cancers
Presenter: F. Lopez-Rios, ES
Session: Session 3
Resources:
Slides
Webcast
Overview of Efficacy of NTRK Inhibitors: Global Perspective
Presenter: V. Subbiah, US
Session: Session 4
Resources:
Slides
Webcast
Overview of Efficacy of NTRK Inhibitors: Asian/Chinese Perspective
Presenter: S. Lu, CN
Session: Session 4
Resources:
Slides
Webcast
Acquired resistance to NTRK inhibitors and development of inhibitors targeting resistance mutations
Presenter: A. Tan, SG
Session: Session 5
Resources:
Slides
Webcast
Looking into the Future: Is there room for combinational approaches to NTRK inhibition?
Presenter: H. H. F. Loong, HK
Session: Session 6
Resources:
Slides
Webcast
Clinical data on NTRK-fused tumours: Sarcoma
Presenter: S. Stacchiotti, IT
Session: Session 7
Resources:
Slides
Webcast
Clinical data on NTRK-fused tumours: Lung Cancer / Thoracic Malignancies
Presenter: Y. Liu, CN
Session: Session 8
Resources:
Slides
Webcast